Chemanalyst22 Aug, 2023Business
Oxcarbazepine prices in the North American region concluded the second quarter of 2023 on a downtrend. The weak price trajectory at the beginning of Q2 could be attributed to sluggish demand and elevated stock levels, significantly impeding market fundamentals. Domestic sales suffered due to higher inflation, while new inquiries from the regional market remained subdued. Consequently, retailers grappled with excessive warehouse inventories that were built up during the pandemic to meet surging demand. Furthermore, imports at North American ports continued to decline. Despite Consumer Price Index (CPI) strengthening in some parts of the region, like the United States where it increased by 0.1% from May to June 2023, local demand saw minimal changes. This sustained the negative trajectory for Oxcarbazepine. Traders and suppliers hesitated to place future orders, focusing on destocking due to disrupted weather conditions in June.
Ll777
Fabet 88you
Luck8
Qq88
79 King
Luxury House Builder
Kasyno Rank
Lucky88 Mobicom
Trendusai
Dw8 A Plataforma Confiável Para Apostas Licenciad